YD54

N/A

Report date: 2025/04/30 09:58:11
NME

Base Information

Drug NameYD54
Drug Alias NameYD54YD-54
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionProbable global transcription activator SNF2L2 degraders
TargetsProbable global transcription activator SNF2L2
Therapy Area/IndicationsLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMd Anderson Usa
China Registration ClassN/A

Develop Information

Active CompaniesMd Anderson Usa
Inactive CompaniesN/A
Active IndicationsLung Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A